Albany Molecular Research, Inc. - AMRI

Albany Molecular Research, Inc. - AMRI AMRI is a global contract research and manufacturing organization in the Life Sciences industry. AMRI is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and quality of life for more than two decades.

AMRI specializes in diverse chemistry, biology and pharmacology, and complex API and drug product manufacturing, from initiation to commercialization.

Whether you’re looking for a CDMO for protein expression, accelerated regulatory path approval, aseptic fill/finish, or ...
06/03/2021

Whether you’re looking for a CDMO for protein expression, accelerated regulatory path approval, aseptic fill/finish, or the development of highly potent APIs, our end-to-end solutions support you on the path to success. Schedule a meeting with us today. http://ow.ly/NC9s50F1wEz

Whether you’re looking for a CDMO for protein expression, accelerated regulatory path approval, aseptic fill/finish, or the development of highly potent APIs, our end-to-end solutions support you on the path to success. Schedule a meeting with us today. http://ow.ly/NC9s50F1wEz

Interested in learning more about our patented premier condensation reagent? AMRI’s T3P® produces high yields at milder ...
06/02/2021

Interested in learning more about our patented premier condensation reagent? AMRI’s T3P® produces high yields at milder reaction conditions and is free of halogen and sulfur. Watch our 30-minute webinar and learn more. http://ow.ly/UM0B50F1psg

Interested in learning more about our patented premier condensation reagent? AMRI’s T3P® produces high yields at milder reaction conditions and is free of halogen and sulfur. Watch our 30-minute webinar and learn more. http://ow.ly/UM0B50F1psg

Did you catch our “Chemistry Through Biology” webinar? Dr. Pete Michels discussed the challenges and triumphs behind tak...
05/28/2021

Did you catch our “Chemistry Through Biology” webinar? Dr. Pete Michels discussed the challenges and triumphs behind taking established chemistry and engineering principles and translating them into practical, scalable, and effective chemical processes used in science and medicine. Replay available now! http://ow.ly/frOI50EXYcj

Did you catch our “Chemistry Through Biology” webinar? Dr. Pete Michels discussed the challenges and triumphs behind taking established chemistry and engineering principles and translating them into practical, scalable, and effective chemical processes used in science and medicine. Replay available now! http://ow.ly/frOI50EXYcj

BIO International may still be a virtual event but nothing can hold us back from meeting your complex chemistry needs! F...
05/28/2021

BIO International may still be a virtual event but nothing can hold us back from meeting your complex chemistry needs! Find AMRI in the BIO One-on-One Partnering platform or reach out to us to schedule a meeting & discuss your drug discovery, development and manufacturing needs. http://ow.ly/lN0q50EXa8A

BIO International may still be a virtual event but nothing can hold us back from meeting your complex chemistry needs! Find AMRI in the BIO One-on-One Partnering platform or reach out to us to schedule a meeting & discuss your drug discovery, development and manufacturing needs. http://ow.ly/lN0q50EXa8A

#ICYMI: 5 takeaways from last month's American Association of Cancer Research (#AACR21) virtual meeting. Highlights incl...
05/25/2021
5 takeaways from AACR, one of the year's top meetings on cancer drugs

#ICYMI: 5 takeaways from last month's American Association of Cancer Research (#AACR21) virtual meeting. Highlights include an emerging target for immunotherapies and a new kind of cell therapy. Check out the BioPharma Dive article here: http://ow.ly/QX1f50EV1Dt

The American Association for Cancer Research's virtual conference featured fresh data on a new kind of cell therapy, an emerging immunotherapy target and a KRAS reboot. 

05/21/2021

AMRI puts the analytical solutions you need just a few clicks away when you shop online with our easy to use eCommerce portal. Check out AMRI Quick Quote today and request a quote for the solutions you need! http://ow.ly/eZbf50EREbA

A quick reminder that you can access white papers, recent webinars, infographics, and more in the AMRI Resource Library ...
05/20/2021

A quick reminder that you can access white papers, recent webinars, infographics, and more in the AMRI Resource Library 24/7! Check out the latest information on topics including #Fermentation, #HighPotency API Manufacturing, and Primary Packaging Solutions: http://ow.ly/vlGL50EREqF #APIs #HPAPIs #chemistry

A quick reminder that you can access white papers, recent webinars, infographics, and more in the AMRI Resource Library 24/7! Check out the latest information on topics including #Fermentation, #HighPotency API Manufacturing, and Primary Packaging Solutions: http://ow.ly/vlGL50EREqF #APIs #HPAPIs #chemistry

Looking for a non-toxic, non-explosive coupling reagent with high thermal stability? Explore T3P, the leading peptide co...
05/19/2021

Looking for a non-toxic, non-explosive coupling reagent with high thermal stability? Explore T3P, the leading peptide coupling and water removal reagent. http://ow.ly/v4EI50EQu8Y

Looking for a non-toxic, non-explosive coupling reagent with high thermal stability? Explore T3P, the leading peptide coupling and water removal reagent. http://ow.ly/v4EI50EQu8Y

The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus.Download o...
05/13/2021

The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus.

Download our latest white paper where we discuss effective strategies to secure and de-risk pharmaceutical supply chains and reveal how AMRI assures the continual production of urgently needed drugs. http://ow.ly/ebP550EMfot

The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus.

Download our latest white paper where we discuss effective strategies to secure and de-risk pharmaceutical supply chains and reveal how AMRI assures the continual production of urgently needed drugs. http://ow.ly/ebP550EMfot

Highly efficacious, innovative medicines need cutting edge delivery systems and pre-filled syringes are stepping up to t...
05/12/2021

Highly efficacious, innovative medicines need cutting edge delivery systems and pre-filled syringes are stepping up to the plate. In this article, learn about the rise of the #PFS and why a strong partnership is the route to success. http://ow.ly/2dpk50ELesq

Highly efficacious, innovative medicines need cutting edge delivery systems and pre-filled syringes are stepping up to the plate. In this article, learn about the rise of the #PFS and why a strong partnership is the route to success. http://ow.ly/2dpk50ELesq

In vitro biochemical assays make the high throughput screening of large compound libraries possible – but without a stro...
05/11/2021

In vitro biochemical assays make the high throughput screening of large compound libraries possible – but without a strong hit-to-lead process, time and money are often wasted seeking out the most promising starting points. Check out our webinar to learn best practices for triaging hits and focusing efforts. http://ow.ly/1WnH50EKewP

In vitro biochemical assays make the high throughput screening of large compound libraries possible – but without a strong hit-to-lead process, time and money are often wasted seeking out the most promising starting points. Check out our webinar to learn best practices for triaging hits and focusing efforts. http://ow.ly/1WnH50EKewP

Based in Wisconsin, Jonathan has a Ph.D. in Medicinal Chemistry and 30+ years of industry experience. In his current rol...
05/04/2021

Based in Wisconsin, Jonathan has a Ph.D. in Medicinal Chemistry and 30+ years of industry experience. In his current role, he specializes in the development, justification, scale-up, and transfer of processes from the laboratory to full production.

Based in Wisconsin, Jonathan has a Ph.D. in Medicinal Chemistry and 30+ years of industry experience. In his current role, he specializes in the development, justification, scale-up, and transfer of processes from the laboratory to full production.

AMRI Adds to Accelerated R&D and Manufacturing Solutions for Orphan Products to Treat Rare Diseases http://ow.ly/u1xU50E...
04/30/2021

AMRI Adds to Accelerated R&D and Manufacturing Solutions for Orphan Products to Treat Rare Diseases http://ow.ly/u1xU50EBXVW

AMRI Adds to Accelerated R&D and Manufacturing Solutions for Orphan Products to Treat Rare Diseases http://ow.ly/u1xU50EBXVW

From amidations and peptide coupling reactions to functional group transformation reactions that include Swern oxidation...
04/29/2021

From amidations and peptide coupling reactions to functional group transformation reactions that include Swern oxidations – discover why T3P® has attracted the attention of innovative pharmaceutical companies worldwide. http://ow.ly/r03q50EBbYH

From amidations and peptide coupling reactions to functional group transformation reactions that include Swern oxidations – discover why T3P® has attracted the attention of innovative pharmaceutical companies worldwide. http://ow.ly/r03q50EBbYH

AMRI brings an expert approach to rapidly developing rare disease drugs.  Schedule a meeting with us to learn more about...
04/27/2021

AMRI brings an expert approach to rapidly developing rare disease drugs. Schedule a meeting with us to learn more about how we tackle the challenges that come with the expedited development of orphan drugs. http://ow.ly/RCOT50EyKef

AMRI brings an expert approach to rapidly developing rare disease drugs. Schedule a meeting with us to learn more about how we tackle the challenges that come with the expedited development of orphan drugs. http://ow.ly/RCOT50EyKef

As medical science advances at a dizzying rate, so does the technology we rely on to assure new treatments are as safe a...
04/26/2021

As medical science advances at a dizzying rate, so does the technology we rely on to assure new treatments are as safe as they are innovative. Read our piece in Pharma Tech Outlook and discovery why drug developers are, more than ever, choosing to rely on CDMOs like AMRI to guide their products from bench to bedside. http://ow.ly/jHDJ50Eu9rl

As medical science advances at a dizzying rate, so does the technology we rely on to assure new treatments are as safe as they are innovative. Read our piece in Pharma Tech Outlook and discovery why drug developers are, more than ever, choosing to rely on CDMOs like AMRI to guide their products from bench to bedside. http://ow.ly/jHDJ50Eu9rl

AMRI’s Brian Haney, Ph.D., discusses the importance of supporting highly potent API projects from discovery to commercia...
04/22/2021

AMRI’s Brian Haney, Ph.D., discusses the importance of supporting highly potent API projects from discovery to commercial production in the latest edition of Pharma’s Almanac. Check it out! http://ow.ly/8DAJ50Eu9iK

AMRI’s Brian Haney, Ph.D., discusses the importance of supporting highly potent API projects from discovery to commercial production in the latest edition of Pharma’s Almanac. Check it out! http://ow.ly/8DAJ50Eu9iK

The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing ...
04/21/2021

The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing weak links and re-igniting discussions around the value of reshoring production. The U.S. Food and Drug Administration (FDA) reports 72% of facilities manufacturing APIs for American drugs are overseas, with 13% in China.

Access our white paper where we discuss effective strategies to secure and de-risk pharmaceutical supply chains and reveal how AMRI assures the continual production of urgently needed drugs. http://ow.ly/B6mC50Eu83Q

The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing weak links and re-igniting discussions around the value of reshoring production. The U.S. Food and Drug Administration (FDA) reports 72% of facilities manufacturing APIs for American drugs are overseas, with 13% in China.

Access our white paper where we discuss effective strategies to secure and de-risk pharmaceutical supply chains and reveal how AMRI assures the continual production of urgently needed drugs. http://ow.ly/B6mC50Eu83Q

Check out this free webinar, presented by senior research scientist Dr. Steef Boerrigter, to learn about optimizing diff...
04/20/2021

Check out this free webinar, presented by senior research scientist Dr. Steef Boerrigter, to learn about optimizing different solid forms as well as the technologies used to achieve them, such as cocrystal and dispersion. http://ow.ly/oXkK50BCCYJ

Check out this free webinar, presented by senior research scientist Dr. Steef Boerrigter, to learn about optimizing different solid forms as well as the technologies used to achieve them, such as cocrystal and dispersion. http://ow.ly/oXkK50BCCYJ

Did you miss our “Solid Form Selection in Drug Development” webinar? Check out the replay today where we discuss the var...
04/15/2021

Did you miss our “Solid Form Selection in Drug Development” webinar? Check out the replay today where we discuss the various technologies for achieving solid forms for inherently problematic substances. http://ow.ly/dSBT50BCD1z

Did you miss our “Solid Form Selection in Drug Development” webinar? Check out the replay today where we discuss the various technologies for achieving solid forms for inherently problematic substances. http://ow.ly/dSBT50BCD1z

#FDA guidance around extractables & leachables continues to evolve. Companies need to consider not only the final produc...
04/08/2021

#FDA guidance around extractables & leachables continues to evolve. Companies need to consider not only the final product and its packaging – but also the components involved in the manufacturing process. Our analytical #chemistry team has you covered from start-to-finish. Learn how AMRI can support your E&L testing needs: http://ow.ly/bTZt50EjVES

#FDA guidance around extractables & leachables continues to evolve. Companies need to consider not only the final product and its packaging – but also the components involved in the manufacturing process. Our analytical #chemistry team has you covered from start-to-finish. Learn how AMRI can support your E&L testing needs: http://ow.ly/bTZt50EjVES

We love seeing how the work of our employees has impacted the science community. Take a look at our research publication...
04/07/2021

We love seeing how the work of our employees has impacted the science community. Take a look at our research publications and patents from the last year. https://bit.ly/3eNsI5k

We love seeing how the work of our employees has impacted the science community. Take a look at our research publications and patents from the last year. https://bit.ly/3eNsI5k

The market for prefilled syringes is forecast to reach $9.7B by 2025, due to an increase in chronic diseases & aging pop...
04/06/2021

The market for prefilled syringes is forecast to reach $9.7B by 2025, due to an increase in chronic diseases & aging populations. Stay up-to-date on the latest PFS challenges & opportunities via our multi-part series: http://ow.ly/31sU50Ei0KJ

The market for prefilled syringes is forecast to reach $9.7B by 2025, due to an increase in chronic diseases & aging populations. Stay up-to-date on the latest PFS challenges & opportunities via our multi-part series: http://ow.ly/31sU50Ei0KJ

Interested in learning more about our patented premier condensation reagent? AMRI’s T3P® produces high yields at milder ...
03/31/2021

Interested in learning more about our patented premier condensation reagent? AMRI’s T3P® produces high yields at milder reaction conditions and is free of halogen and sulfur. Speak with our experts and learn more! http://ow.ly/B7yf50EcBCY

Interested in learning more about our patented premier condensation reagent? AMRI’s T3P® produces high yields at milder reaction conditions and is free of halogen and sulfur. Speak with our experts and learn more! http://ow.ly/B7yf50EcBCY

Sign up for our webinar where we’ll discuss the effect COVID-19 has been having on sterile manufacturing capacity within...
03/30/2021

Sign up for our webinar where we’ll discuss the effect COVID-19 has been having on sterile manufacturing capacity within CDMOs and some options drug companies have to mitigate these issues. http://ow.ly/uR7r50E8EaN

Sign up for our webinar where we’ll discuss the effect COVID-19 has been having on sterile manufacturing capacity within CDMOs and some options drug companies have to mitigate these issues. http://ow.ly/uR7r50E8EaN

Webinar Alert: Join us as we discuss the recent shortage of sterile manufacturing capacity within CDMOs, the push to kee...
03/25/2021

Webinar Alert: Join us as we discuss the recent shortage of sterile manufacturing capacity within CDMOs, the push to keep manufacturing within US boarders, and how AMRI is responding to client needs. This is a webinar you won’t want to miss! http://ow.ly/K92o50E8EaO

Webinar Alert: Join us as we discuss the recent shortage of sterile manufacturing capacity within CDMOs, the push to keep manufacturing within US boarders, and how AMRI is responding to client needs. This is a webinar you won’t want to miss! http://ow.ly/K92o50E8EaO

At AMRI, our employees are hard at work every day developing life-changing science. We recently rounded up our research ...
03/18/2021

At AMRI, our employees are hard at work every day developing life-changing science. We recently rounded up our research publications and patents from the last year. Check it out! https://bit.ly/3eNsI5k

At AMRI, our employees are hard at work every day developing life-changing science. We recently rounded up our research publications and patents from the last year. Check it out! https://bit.ly/3eNsI5k

What makes a promising starting point for a drug discovery program? Join our presenters as they discuss the importance o...
03/16/2021

What makes a promising starting point for a drug discovery program? Join our presenters as they discuss the importance of hit-to-lead optimization, sharing strategies to triage hits and improve success rates. Watch our hit-to-lead webinar today! http://ow.ly/mVTZ50E0E4s

What makes a promising starting point for a drug discovery program? Join our presenters as they discuss the importance of hit-to-lead optimization, sharing strategies to triage hits and improve success rates. Watch our hit-to-lead webinar today! http://ow.ly/mVTZ50E0E4s

Some have called it the coupling reagent of the future. For us, it’s just another superior output of our patented manufa...
03/15/2021

Some have called it the coupling reagent of the future. For us, it’s just another superior output of our patented manufacturing process. Visit our website to learn more about T3P and schedule a meeting with us today. https://bit.ly/3tnhLLH

Some have called it the coupling reagent of the future. For us, it’s just another superior output of our patented manufacturing process. Visit our website to learn more about T3P and schedule a meeting with us today. https://bit.ly/3tnhLLH

Our experts are live at the World ADC virtual event and ready to discuss ADC discovery and development. Schedule time wi...
03/09/2021

Our experts are live at the World ADC virtual event and ready to discuss ADC discovery and development. Schedule time with us to learn how we can take your ADC project from early-stage development to full-scale manufacturing. http://ow.ly/P1kJ50DxcZk

Our experts are live at the World ADC virtual event and ready to discuss ADC discovery and development. Schedule time with us to learn how we can take your ADC project from early-stage development to full-scale manufacturing. http://ow.ly/P1kJ50DxcZk

Address

26 Corporate Circle
Albany, NY
12203

Alerts

Be the first to know and let us send you an email when Albany Molecular Research, Inc. - AMRI posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Albany Molecular Research, Inc. - AMRI:

Videos

Nearby health & beauty businesses